Identification of lung cancer with high sensitivity and specificity by blood testing

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Leidinger, Petra ^a   Keller, Andreas ^b   Heisel, Sabrina ^a   Ludwig, Nicole ^a   Rheinheimer, Stefanie ^a   Klein, Veronika ^a   Andres, Claudia ^b   Staratschek Jox, Andrea ^c   Wolf, Jürgen ^d   Stoelben, Erich ^d   Stephan, Bernhard ^a   Stehle, Ingo ^a   Hamacher, Jürg ^e   Huwer, Hanno ^f   Lenhof, Hans Peter ^b   Meese, Eckart ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e UNIVERSITY OF BERN   (Switzerland)

^f Voelklingen Heart Center   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD EXAMINATION; CANCER CLASSIFICATION; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; ALGORITHM; BLOOD; BLOOD ANALYSIS; EVALUATION; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

AGED; ALGORITHMS; BLOOD CHEMICAL ANALYSIS; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77952474524     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-18     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58(2):71-96. 10.3322/CA.2007.0010, 18287387.
2. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132(3 Suppl):234S-242S. 10.1378/chest.07-1378, 17873171.
3. Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L, Mariotto A, Feuer E, Edwards B. SEER Cancer Statistics Review, 1975-2002. 2002, National Cancer Institute. Bethesda, MD.
4. Henschke CI, Yankelevitz DF. CT screening for lung cancer: update 2007. Oncologist 2008, 13(1):65-78. 10.1634/theoncologist.2007-0153, 18245013.
5. Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Takashima S, Hasegawa M, Kawakami S, Kubo K, Haniuda M, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001, 84(1):25-32. 10.1054/bjoc.2000.1531, 2363609, 11139308.
6. Artinian V, Kvale PA. Update in screening of lung cancer. Respirology 2005, 10(5):558-566. 10.1111/j.1440-1843.2005.00750.x, 16268907.
7. Marshall E. Medicine. A bruising battle over lung scans. Science 2008, 320(5876):600-603. 10.1126/science.320.5876.600, 18451275.
8. Reich JM. A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening. Thorax 2008, 63(4):377-383. 10.1136/thx.2007.079673, 18364449.
9. Comtesse N, Zippel A, Walle S, Monz D, Backes C, Fischer U, Mayer J, Ludwig N, Hildebrandt A, Keller A, et al. Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. Proc Natl Acad Sci USA 2005, 102(27):9601-9606. 10.1073/pnas.0500404102, 1172238, 15983380.
10. Brichory F, Beer D, Le Naour F, Giordano T, Hanash S. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res 2001, 61(21):7908-7912.
11. Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG, Hanash SM. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci USA 2001, 98(17):9824-9829. 10.1073/pnas.171320598, 55537, 11504947.
12. He P, Naka T, Serada S, Fujimoto M, Tanaka T, Hashimoto S, Shima Y, Yamadori T, Suzuki H, Hirashima T, et al. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci 2007, 98(8):1234-1240. 10.1111/j.1349-7006.2007.00509.x, 17506794.
13. Tureci O, Mack U, Luxemburger U, Heinen H, Krummenauer F, Sester M, Sester U, Sybrecht GW, Sahin U. Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. Cancer Lett 2006, 236(1):64-71. 10.1016/j.canlet.2005.05.008, 15992994.
14. Yamaguchi K, Patturajan M, Trink B, Usadel H, Koch W, Jen J, Sidransky D. Circulating antibodies to p40(AIS) in the sera of respiratory tract cancer patients. Int J Cancer 2000, 89(6):524-528. 10.1002/1097-0215(20001120)89:6<524::AID-IJC10>3.0.CO;2-O, 11102898.
15. Yamamoto A, Shimizu E, Ogura T, Sone S. Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients. Int J Cancer 1996, 69(4):283-289. 10.1002/(SICI)1097-0215(19960822)69:4<283::AID-IJC8>3.0.CO;2-T, 8797869.
16. Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, Tureci O, Wiewrodt R, Barnes AC, Robertson JF. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 2008, 63(3):228-233. 10.1136/thx.2007.083592, 17932110.
17. Patz EF, Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, Herndon JE. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 2007, 25(35):5578-5583. 10.1200/JCO.2007.13.5392, 18065730.
18. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 2006, 1(6):513-519. 10.1097/01243894-200607000-00003, 17409910.
19. Zhong L, Hidalgo GE, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med 2005, 172(10):1308-1314. 10.1164/rccm.200505-830OC, 2718416, 16109979.
20. Leidinger P, Keller A, Ludwig N, Rheinheimer S, Hamacher J, Huwer H, Stehle I, Lenhof HP, Meese E. Toward an early diagnosis of lung cancer: an autoantibody signature for squamous cell lung carcinoma. Int J Cancer 2008, 123(7):1631-1636. 10.1002/ijc.23680, 18649359.
21. Bussow K, Cahill D, Nietfeld W, Bancroft D, Scherzinger E, Lehrach H, Walter G. A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library. Nucleic Acids Res 1998, 26(21):5007-5008. 10.1093/nar/26.21.5007, 147919, 9776767.
22. Leidinger P, Keller A, Heisel S, Ludwig N, Rheinheimer S, Klein V, Andres C, Hamacher J, Huwer H, Stephan B, et al. Novel autoantigens immunogenic in COPD patients. Respir Res 2009, 10:20. 10.1186/1465-9921-10-20, 2667165, 19284601.
23. Soille P. Morphological Image Analysis. 2003, Springer, Berlin, Second.
24. Vapnik V. The Nature of Statistical Learning Theory. 2000, Springer.
25. Hirsch FR, Franklin WA, Gazdar AF, Bunn PA. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 2001, 7(1):5-22.
26. Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK. Lung cancer risk prediction: a tool for early detection. Int J Cancer 2007, 120(1):1-6. 10.1002/ijc.22331, 17058200.
27. Humphrey LL, Teutsch S, Johnson M. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2004, 140(9):740-753.
28. Lobo ED, Hansen RJ, Balthasar JP. Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci 2004, 93(11):2645-2668. 10.1002/jps.20178, 15389672.
29. Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, Riggs AD, Pfeifer GP. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci USA 2008, 105(1):252-257. 10.1073/pnas.0710735105, 2224196, 18162535.
30. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Lin WM, Province MA, Kraja A, Johnson LA, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007, 450(7171):893-898. 10.1038/nature06358, 2538683, 17982442.
31. Ogiwara H, Kohno T, Nakanishi H, Nagayama K, Sato M, Yokota J. Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer. Oncogene 2008, 27(35):4788-4797. 10.1038/onc.2008.113, 18408757.
32. Tan D, Deeb G, Wang J, Slocum HK, Winston J, Wiseman S, Beck A, Sait S, Anderson T, Nwogu C, et al. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization. Diagn Mol Pathol 2003, 12(4):201-211. 10.1097/00019606-200312000-00004, 14639106.